©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Crystal Structure of S-Adenosylmethionine Synthetase (*)

(Received for publication, June 1, 1995; and in revised form, October 5, 1995)

Fusao Takusagawa (1)(§) Shigehiro Kamitori (1) Shintaro Misaki (1) George D. Markham (2)

From the  (1)Departments of Chemistry and Biochemistry, University of Kansas, Lawrence, Kansas 66045-0046 and the (2)Institute for Cancer Research, The Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The structure of S-adenosylmethionine synthetase (MAT, ATP:L-methionine S-adenosyltransferase, EC 2.5.1.6.) from Escherichia coli has been determined at 3.0 Å resolution by multiple isomorphous replacement using a uranium derivative and the selenomethionine form of the enzyme (SeMAT). The SeMAT data (9 selenomethionine residues out of 383 amino acid residues) have been found to have a sufficient phasing power to determine the structure of the 42,000 molecular weight protein by combining them with the other heavy atom derivative data (multiple isomorphous replacement). The enzyme consists of four identical subunits; two subunits form a spherical tight dimer, and pairs of these dimers form a peanut-shaped tetrameric enzyme. Each pair dimer has two active sites which are located between the subunits. Each subunit consists of three domains that are related to each other by pseudo-3-fold symmetry. The essential divalent (Mg/Co) and monovalent (K) metal ions and one of the product, P(i) ions, were found in the active site from three separate structures.


INTRODUCTION

In biological systems, there are a myriad of reactions in which methyl groups are transferred from a few types of methyl donors to a wide variety of methyl acceptors. Among biological methyl group donors, S-adenosylmethionine (AdoMet), (^1)discovered by Cantoni in 1953(1) , is the most widely used, while 5-methyltetrahydrofolic acid, methylcobalamin, and betaine are involved in far fewer methylation reactions. The activated methyl cycle involving AdoMet is illustrated below (Fig. S1).


Figure S1: Scheme 1Activated methyl cycle.



AdoMet, synthesized from L-methionine and ATP, transfers a methyl group to a methyl acceptor molecule, yielding S-adenosylhomocysteine. S-Adenosylhomocysteine is subsequently hydrolyzed to adenosine and homocysteine, the latter of which can be metabolized to methionine.

Methylation reactions involving AdoMet are increasingly being recognized as significant control factors in the regulation of a variety of cellular functions. Methylation of nucleic acids is known to have regulatory effects on DNA replication and transcription and RNA translation. Protein methylation is involved in the regulation of a variety of metabolic processes such as bacterial chemotaxis(2, 3) , sperm mobility(4) , and release of neurotransmitters(5) . AdoMet is also the methyl donor to a vast number of small molecules (e.g. in the biosynthesis and/or metabolism of various catecholamine neurotransmitters). AdoMet is being used in clinical trials for treatment of depression(6) , liver injury(7) , and as a potential cancer chemopreventive agent(8) . In addition to its role as a methyl donor, AdoMet undergoes decarboxylation to generate the propylamine donor in the biosynthesis of the polyamines, spermine and spermidine, which are widely distributed in nature and appear to be involved in cellular proliferation(9) . Recently, inhibition of the metabolism of AdoMet has been found to be an important target for development of the chemotherapeutic agents for neoplastic and viral diseases(10, 11) . Regland and Gottfries (12) have proposed that slowed synthesis of AdoMet is a pathogenetic mechanism common to the dementia seen in Alzheimer's disease, Down's syndrome, and the acquired immunodeficiency syndrome.

The formation of AdoMet is catalyzed solely by AdoMet synthetase (MAT, ATP:L-methionine S-adenosyltransferase, EC 2.5.1.6). The synthesis of AdoMet occurs in an unusual two-step reaction in which the complete tripolyphosphate chain is cleaved from ATP as AdoMet is formed, and the tripolyphosphate is subsequently hydrolyzed to pyrophosphate (PP(i)) and orthophosphate (P(i)) before the sulfonium product (AdoMet) is released, giving the overall reaction shown below(13) .

Thus, the enzyme uniquely catalyzes reactions at both ends of the tripolyphosphate chain in a defined temporal sequence. AdoMet synthetase requires divalent metal ions for activity (e.g. Mg, Co) and is greatly activated by certain monovalent cations such as K.

The amino acid sequences of the enzyme from Escherichia coli(14, 15) , Saccharomyces cerevisiae(16, 17) , Arabidopsis thaliana(18, 19) , rat liver(20) , rat kidney (21) , human liver(22) , human kidney(23) , and the leaf of Dianthus caryophyllus(24) have been reported deduced based on DNA sequences. In all organisms studied so far, sequence homologies show that AdoMet synthetase is an exceptionally well conserved enzyme through evolution. No biological data regarding the amino acid residues involved in the active site of MAT has been reported. The first crystallization of MAT was reported by Gilliland et al.(25) ; however, no subsequent work was reported. The determination of the three-dimensional structure of the enzyme is essential for elucidation of the unique catalytic mechanism and will also facilitate development of effective inhibitors of this enzyme. In the present paper, we describe the x-ray structures of three MAT complexes with the product P(i) ions and various metal ions.


EXPERIMENTAL PROCEDURES

Crystallization

AdoMet synthetase (MAT) was prepared from E. coli strain DM50pK8, a strain which harbors the plasmid pK8 which contains the structural gene for the enzyme and produces the MAT as nearly 20% of the total cell protein(14) . The enzyme was purified to electrophoretic homogeneity using methods described previously(26, 27) . MAT, in which all methionine residues were replaced by selenomethionine (SeMAT), was prepared by transfer of pK8 into the methionine auxotrophic strain DL41, followed by growth of DL41pK8 on defined media containing selenomethionine in place of methionine as described by Hendrickson(28) . The SeMAT protein was purified in the same fashion as the unsubstituted enzyme and displayed no alterations in physical properties. The degree of selenomethionine substitution was determined by an electrospray mass spectrometry as described below.

Crystals of the native enzyme (MAT) and SeMAT from E. coli were grown in a buffer containing 100 mM potassium phosphate (pH 7.0), 10 mM MgCl(2), 33% (v/v) saturated ammonium sulfate with the protein concentration at 10 mg/ml. The hexagonal bipyramidal shaped crystals were grown at 26 °C for 2 weeks. Crystals of the native enzyme containing Co ions in the active site (MAT-Co) were grown from a similar solution which contained 10 mM CoCl(2) instead of 10 mM MgCl(2). The uranium derivative crystals were prepared by the soaking method; native crystals were incubated in an artificial mother liquor containing 50 mM Tris-malate buffer (pH 7.0), 10 mM MgCl(2), 40% saturated ammonium sulfate, and 5 mM UO(2)(NO(3))(2) for 5 h before they were mounted into the capillary.

Data Measurement

Preliminary precession photographs showed that the crystals belonged to the hexagonal crystal system with space group P6(2)22 or its enantiomorph with cell dimensions a = b = 129 Å, c = 139 Å. As the crystals decayed very quickly under the x-ray exposure conditions required for data collection, the total intensity data were obtained from several fresh crystals. Diffraction data for the native enzyme (MAT) and the SeMAT were measured on a locally modified DIP100S imaging plate x-ray diffractometer (MAC Science, Japan), while data for the uranium derivative (MAT-U) and the cobalt derivative (MAT-Co) were measured on the MARK III multiwire area detector x-ray diffractometer at University of California at San Diego(29) ; CuKalpha radiation was used in both cases. The data of the native enzyme and the SeMAT were processed with the program ELMS(30) , whereas the data of the MAT-U and the MAT-Co were processed by the software associated with MARK III (29) . Integrated reflections were scaled and reduced with locally developed programs(31) . The data statistics are given in Table 1.



Structure Determination

The uranium positions (two sites) were located in a difference Patterson map and were refined by the locally developed program HEVY. The positions are listed in Table 2. Initial protein phases were determined from the single isomorphous replacement (SIR) data in conjunction with solvent flattening(32) . The phases of the 4.0 Å resolution isomorphous data were refined and gradually extended to 3.0 Å resolution by solvent flattening. The space group, P6(2)22, was selected by reference to the observed alpha-helix configuration. Although the electron density map calculated with the initial phases showed the molecular boundaries and all alpha-helices and beta-sheets, it was difficult to trace the main chain correctly and to assign the side chain groups.



The difference electron density map calculated with coefficients (F - F) and the phases obtained from the SIR described above showed nine peaks clearly (>7) for the selenium atoms of the SeMet residues (Fig. 1). The positions of the selenium atoms were refined by the locally developed program HEVY. The relatively high B-values of selenium atoms refined by using the centric reflections might be due to some systematic errors introduced by the many crystals used to collect each data set, but all SeMet residues in SeMAT structure are well-ordered in the final structure. The calculated phasing power of the SeMAT data (1.76) was as strong as that of the MAT-U derivative data (1.64). Therefore, the protein phases were determined by the SeMAT isomorphous replacement data in conjunction with solvent flattening, in order to test whether the SeMAT data have enough phasing power as indicated by the calculation and whether the positions of the selenium atoms are reliable. As shown in Fig. 2, the map calculated using the phases determined from the SeMAT data had the similar electron density distribution seen in the map calculated from MAT-U data. Thus, the MIR phases (4.0 Å resolution) were obtained by combining the phase distribution functions of uranium and selenium derivatives. The phases were refined and extended from 4.0 Å to 3.0 Å resolution by solvent flattening. It is noted that the SeMet forms of enzymes have recently been used successfully for one of the MIR derivatives(33, 34) .


Figure 1: The difference electron density map calculated with the coefficients of (F - F) and the phase angles obtained by the single isomorphous replacement (SIR) using the UO(2) derivative data. Nine peaks (>7) centered on the selenium atoms of the nine selenomethionine residues are visible. The map was calculated with 10-4.0 Å resolution data, and the contour was drawn at 5.0 level.




Figure 2: Electron density maps of the B5 beta-strand (QGLMFGYATN) containing various sized residues. A, SIR map phased by the MAT-U derivative; B, SIR map phased by the SeMAT; C, MIR map phased by the MAT-U and SeMAT; D, final (2F - F) map; E, omit map. The SIR and MIR maps were calculated with the phases refined and extended by solvent flattening. The omit map was calculated after 30 cycles of the positional refinement by X-PLOR. The contours are drawn at 1.5 level for map A, B, C, and D and 3.0 for map E. The final model is superimposed in the maps.



The map calculated with the new phases was improved (Fig. 2). The entire main chain except for Ala^1-His^3, Ile-Asp, and Gly-Lys was traced without ambiguity, and the side chain groups of 343 out of 383 residues were placed in the electron density peaks contoured at 1.1 level. The initial model was built on an IRIS work station using the program TOM/FRODO(35, 36) . The model was refined with the positional protocol and then the simulated annealing procedure of X-PLOR(37) . The model was rebuilt where necessary, and previously undefined residues were built into the electron density map.

During later stages of refinement, difference maps calculated with coefficients of (F(o) - F(c)), and calculated phases showed several significant residual electron density peaks in the region of active site (Fig. 3). The electron density peaks were assigned to two P(i), one K, and two Mg ions based on the size of the electron density, refined temperature factors, and polar environment, and those ions were introduced into the refinement. Assignment of the divalent ions (Mg) was confirmed with the structure analysis of MAT-Co which is described below. The additional residual electron density peak found near the center of tight dimer and on the 2-fold axis was significant and assigned to a K ion based on the size of the electron density peak and polar environment. Refinement of isotropic temperature factors for individual atoms was carried out by the individual B-factor refinement procedure of X-PLOR using bond and angle restraints. The thermal parameters of the two P(i) and metal ions were relatively large in comparison with those of the amino acid residues constituting the active site, suggesting that the ion sites are partially occupied. After four cycles of model building and refinement, all residues from 1 to 101 and 108 to 383 were built into the electron density map. The residues 102 to 107, which are outside the active site, were not visible in the electron density maps and were assumed to be heavily disordered. Residues 102 to 107 were arbitrarily placed using a TOM/FRODO routine; however, those residues were not included in the refinement.


Figure 3: Difference electron density maps calculated after 30 cycles of positional refinement of the protein structure (not including the P(i) and metal ions) by X-PLOR. The contours are drawn at 3 level. The final model is superimposed on the map. The Mg/Co ions (X) and the P(i) ions are shown in the center of maps. The residual electron density peak of the K ion (X) is visible in the left side of the maps.



The structure determination has been verified by the following procedures. The R-factor distributions in several resolution shells are reasonably uniform (Table 3), and the free R(38) calculated using 10% reflections selected randomly is relatively low (0.26). The structure was also checked by the computer program PROFILE 3D(39) , and no unusual connectivity has been found in the protein structure (Fig. 4). Also, a standard protein structure verification program, PROCHECK(40) , does not indicate any unusual feature in the structure. The Ramachandran plot (41) indicates that nearly all residues are in allowed conformations (Fig. 5). The root mean square deviations of bond distances, angles, and torsion angles from the ideal geometry data are relatively small (Table 1). As shown in Fig. 2, an omit map calculated after 30 cycles of the positional refinement reproduces the similar electron density distribution seen in the final (2F(o) - F(c)) map. Finally, the correctness of the main chain connectivity is strongly supported by the nine methionine sites determined from the SeMet-form enzyme data. As described above, the difference electron density map calculated with the coefficients of (F - F), and the phases obtained by the SIR using the UO(2) derivative data showed nine peaks (>7) at the positions of the selenium atoms of nine selenomethionine residues (Fig. 1). There is little chance of incorrectly tracing the peptide chain and still correctly locating the nine methionine sites. The parameters for the structure determination and refinement are listed in Table 1. The coordinates have been deposited in the Protein Data Bank (code numbers 1XRA, 1XRB, and 1XRC).




Figure 4: Profile window plot of the final model of MAT. The vertical axis gives the average three-dimensional-one-dimensional score for residues in a 21-residue sliding window. In general, the negative scores suggest connectivity problems in the regions. The total score of entire residues is 169, which is quite high.




Figure 5: Ramachandran plot of the main-chain dihedral angles for the final atomic model. Glycine residues are indicated as triangles. Asp is located slightly outside of the allowed region ( = 81°, = 137°).



The structures of MAT-Co and SeMAT were initially refined with the coordinates of the protein structure described above. The difference map for SeMAT calculated after 30 cycles of the positional protocol, showed the same residual electron densities in the active site as were observed in the MAT structure. The residual electron density peaks in the MAT-Co structure were also quite similar to those of the MAT structure. However, the electron density peaks at the positions where the Mg ions were assigned in the MAT structure were significantly higher in the MAT-Co structure (Fig. 3). On the basis of this difference in the residual electron density peaks, the binding locations for the divalent ions (Mg or Co) in the active site were deduced.


RESULTS AND DISCUSSION

New Amino Acid Sequence

As described above, the difference electron density map calculated with the coefficients of (F - F) and the phases obtained by the SIR using the UO(2) derivative data showed nine peaks (>7), which agrees with nine methionine residues in the sequence determined previously(14) . However, amino-terminal sequences of both enzyme forms (MAT and SeMAT) showed alanine 2 as the terminus, indicating that the amino-terminal methionine encoded by the gene had been removed. Thus, the nine methionine residues found by x-ray analysis did not agree with the eight deduced from the published gene sequence(14) . Therefore, the number of selenomethionine residues incorporated into the enzyme was determined independently by mass spectrometry. Molecular masses of the Met-enzyme and the SeMet-enzyme were determined by an electrospray-mass spectrometry at the Protein and Carbohydrate Structure Facility at the University of Michigan. Masses of 41,843.0 ± 10.5 and 42,249.7 ± 9.6 were obtained for the unsubstituted enzyme and the SeMet-enzyme, respectively. The mass difference indicates that 8.7 ± 0.3 SeMet residues are incorporated per subunit, which agrees with the value of nine predicted from the x-ray data. Therefore, the metK gene was completely resequenced using the Sequenase polymerase (U. S. Biochemical Corp.) rather than the Klenow polymerase used previously. Several errors in the original sequence were found, apparently resulting from the inability of the Klenow fragment to correctly read some regions of the DNA. The revised sequence will be deposited in GenBank. The new sequence of metK gene indeed contains 10 methionine residues including the amino-terminal residue. The molecular weight (41,835.1) calculated from the new sequence is in much better agreement with the molecular weight (41,843.0) obtained by an electrospray-mass spectrometry than the molecular weight (41,935.6) calculated from the earlier sequence. The structure has been solved based on the new sequence as listed in Table 4.



Overall Structure of the Tetrameric Enzyme

The structures of the MAT protein in the three individual crystal structures described here are essentially indistinguishable. The root mean square deviations among the three MAT structures (MAT, SeMAT, and MAT-Co) are summarized in Table 5. Particularly the structures of MAT and SeMAT are equivalent within experimental uncertainty, suggesting that replacement of the methionine residues with selenomethionine does not change the structure of the protein. On the other hand, the MAT-Co structure deviates significantly from the other two. As will be discussed below, these differences might be due to the different coordination schemes around the divalent metals. The other possible explanation for the deviation is due to different data sources, i.e. the MAT and SeMAT data were measured on a DIP100S imaging plate diffractometer, whereas the MAT-Co data were measured on the MARK-III multiwire detector x-ray diffractometer.



MAT consists of four identical subunits related by 222 symmetry (Fig. 6). The four subunits are denoted subunits A, B, C, and D. Pairs of subunits (A and B or C and D) strongly interact with each other to form a spherical tight dimer, and these tight dimers associate to a peanut-shaped tetrameric enzyme. The interactions between the tight dimers appear to be much weaker than the subunit-subunit interactions within the tight dimer. Each tight dimer has two active sites located between subunits A and B or C and D, with amino acid residues from both subunits contributing to each active site (Fig. 6). We use the following convention to distinguish between residues in subunits A and B. A residue name with no added symbol refers to a residue of subunit A; a residue name with an appended asterisk refers to a residue of subunit B. For example, Glu means Glu of subunit A, and Arg* means Arg of subunit B. The convention also applies to elements of secondary structure (alpha-helix: H1, H1*; beta-strand: B1, B1*, etc.).


Figure 6: Tetrameric structure of MAT. Subunits A, B, C, and D related by 222 symmetry are marked by letters at each carboxyl-terminal, respectively. The two P(i), two Mg, and one K ions found in the active site between subunits A and B are illustrated with stick bonds and asterisks, respectively.



Overall Structure of the Subunit

Each subunit of MAT is composed of three domains, with the peptide chain organized into nine alpha-helices, eleven beta-strands, and five 3 one-turn helices assigned by the program PROCHECK (40) ( Fig. 7and 8). The three domains are denoted the amino-terminal domain (residues 1-12 and 129-233), the central domain (residues 13-101 and 234-268), and the carboxyl-terminal domain (residues 108-128 and 269-383) are related to each other by pseudo-3-fold symmetry (Fig. 7). In each domain, two alpha-helices are located on a beta-sheet formed by three or four beta-strands. A long alpha-helix, followed by a pair of anti-parallel beta-strands and a short alpha-helix is a common secondary structural motif in each domain (H3-B6-B7-H4 in the amino-terminal domain, H1-B2-B3-H2 in the central domain, and H6-B10-B11-H7 in the carboxyl-terminal domain) (Fig. 8). The amino-terminal domain consists of two alpha-helices and four beta-strands in which B1, B6, and B7 compose an anti-parallel beta-sheet and the edge beta-strand, B8, runs parallel to B7. Similarly the central domain has two alpha-helices and four beta-strands, but a beta-strand B9 corresponding to B1 in the amino-terminal is relatively short. The missing portion of the beta-strand is replaced with the end of the large core loop (Gly-Ser); these regions interact with B2 as if to form an anti-parallel beta-sheet. In the carboxyl-terminal domain, the fourth beta-strand, which is missing, and the corresponding polypeptide chain forms two additional alpha-helices. To our knowledge, this secondary structure topology represents a novel protein fold. The electron density map of six amino acid residues(102-107) which are near to, but outside of, the active site are too weak to trace correctly. Since the distance between the alpha-carbons of Asp and Arg is 16 Å, the peptide chain of the missing six residues should be relatively extended and apparently has variable, multiple conformations. These undefined residues might form a ``flexible loop'' over the active site cleft, comparable to the flexible loop found in triosephosphate isomerase (42) and lactate dehydrogenase(43) .


Figure 7: A, Calpha trace of the subunit of MAT with two P(i) ions, two Mg ions (solid circle) and one K ion (open circle). The three domains are illustrated with the thin, open, and thick bonds, respectively. Selected sequence numbers are added near the Calpha atoms. The P(i) ions (solid bonds), Mg ions (filled circles), and K ion (open circle) are illustrated. The unresolved six amino acid residues(102-107) built arbitrarily are drawn with dashed lines. B, ribbon representation of the subunit.




Figure 8: Topology diagram showing the secondary structural similarities of the three domains of MAT. The alpha-helices, beta-strands, and 3 helices are indicated by rectangles, arrows, and circles, respectively.



Three crystal structures of methyltransferases with bound AdoMet, catechol O-methyltransferase(44) , HhaI DNA methyltransferase(45) , and TaqI DNA methyltransferase (46) have recently been reported. The AdoMet binding domains of these methyltransferases are strikingly similar to each other, indicating that many methyltransferases may have a common structure(47) . However, the AdoMet binding pocket of the E. coli methionine repressor(48) , the only other AdoMet binding protein with a structure determined by x-ray analysis, has no resemblance to the AdoMet-binding pockets found in the methyltransferases. MAT has no structural similarity to either of these methyltransferases or to the repressor.

Interaction between Subunits

A tight dimer is composed of subunits A and B or C and D, as described above. The contact surfaces between the subunits are mostly flat, and thus the subunit boundary is clearly distinguishable (Fig. 6). The major intersubunit interaction is a hydrophobic interaction between three sets of beta-sheets (Fig. 9A). In the central region of the tight dimer, the core loop and short alpha-helix (H5) in the central domain of subunit A interact quite extensively with the analogous regions of subunit B through mainly polar interactions. Glu and Thr especially are both involved in a salt bridge with Arg*, whereas Gly and Gly* are coordinated to the K ion located on the 2-fold axis. These polar interactions in the central region of the tight dimer appear to construct a rigid framework for the active sites.


Figure 9: A, interactions between two subunits in a tight dimer. The beta-sheets and the core loop of subunit A are shown by solid lines, and those of subunit B by open lines. A K ion located in the center of the dimer is indicated by an open circle. The beta-sheets mainly interact by hydrophobic interactions, whereas the central region including the central core loop and the K ion participate in hydrogen bonds between the subunits. B, interaction between the tight dimers. The residues belonging to subunit D are drawn with open bonds. Hydrogen bonds between Ser . . . Ser* are indicated by dashed lines. The side chains (-CH(2)SH) of Cys drawn with solid bonds and filled atoms in the two subunits point in opposite directions.



Interactions between the tight dimers appear to be less extensive. There is only one residue, Ser in the B4 beta-strand, that is involved in polar interactions between subunit A and subunit C. Ser is the only residue which participates in the 2-fold intersubunit hydrogen bonds between subunits A and D. However, the measured dissociation constant for the equilibrium between the tetramer and two dimers is less than 10M(49) . It is noteworthy that upon modification of the enzyme with the sulfhydryl reagent N-ethylmaleimide, which reacts with both Cys and Cys in each subunit, the tetramer dissociates to two dimers(49) . Furthermore, a site-directed mutagenesis change of Cys to Ala yields an enzyme that exists as a mixture of dimers and tetramers, while changing Cys to Ala has no effect on the aggregation state (50) . Although Cys is located on the border between dimers, no strong interaction is observed (Fig. 9B). However, Cys is a conserved amino acid residue of MAT in various organisms suggesting that this residue plays an important role in dimer formation of the enzyme. Thus, the structure of the interface between the dimers might be changed substantially by replacing Cys with Ala.

Active Site

It should be noted that this is the first study describing the amino acid residues involved in the active site of MAT. There is a large, deep cleft between the two subunits ( Fig. 6and 10). As shown in Fig. 3and Fig. 10, the electron density maps show clearly two P(i) ions (one of the products) and three metal ions (one K and two Mg/Co) in the cleft. Thus, this region must be the active site of the enzyme. Possible interactions between amino acid residues and the P(i) and metal ions are illustrated in Fig. 11. Although several interactions appear to be slightly different among the three structures (especially coordination schemes of the Mg and Co ions), these differences are insignificant at the 3.0 Å resolution of these structures.


Figure 10: The final (2F - F) map around active site of MAT-Co complex. A, electron density peaks of two P(i), two Co, and one K in the active site showing the deep cleft between the two subunits. B, electron density distribution in the bottom of the active site showing well-defined electron density peaks for the amino acid residues. Contours are drawn at 1.0 level for P(i), Co, and K ions and 1.5 level for amino acid residues.




Figure 11: The active site geometry with P(i) and metal ions. Possible polar interactions (hydrogen and coordinate bonds) are indicated by thin lines3. P(i) and metal ions are illustrated by the solid bonds and filled circles, respectively. The hydrogen and coordination bonds are defined as donor-acceptor distance to be less than 3.3 Å and metal-oxygen distance to be less than 2.5 Å, respectively.



His^14*(N2) and Lys*(N) hydrogen-bond to one P(i), whereas Lys(N) and Lys*(N) hydrogen-bond to the other P(i). Lys*(N) appears to participate by providing the bridging hydrogen bonds between the two P(i) ions. Interactions between these positively charged residues and the negatively charged oxygen atoms of the P(i) ions appear to neutralize the individual charges. Some of these positively charged residues may be involved in either the displacement of the tripolyphosphate chain from ATP during AdoMet formation or the subsequent hydrolysis of the tripolyphosphate to PP(i) and P(i).

Two Mg (or Co) ions are separated by 5 Å, and those ions bridge two P(i) ions in a trigonal pyramidal fashion, i.e. each divalent ion is coordinated to two oxygen atoms of one P(i) ion and to one oxygen atom of the other P(i) ion. The negatively charged Asp and Asp* residues each coordinate to one of the two Mg (or Co) ions from the side opposite to the P(i) ions. Additionally, two oxygen atoms (O1 of Glu^8* and O1 of Asp) are located within 4.0 Å from the Co(1) ion. Similarly, the Co(2) ion is surrounded by two additional oxygen atoms (O1 of Glu and O of Cys*). These oxygen atoms may be involved in coordination bonds to the Co ions. A similar environment is observed around the Mg ions. It is not clear whether these divalent ions bind to the enzyme in the same fashion when ATP binds at the active site.

Cantoni (1) reported that divalent metal ions are essential for MAT activity. An EPR spectroscopic study with Mn has indicated that one metal ion binds to the enzyme in the absence of substrates and a second metal ion binds as a complex with the substrate ATP(27) . When Mn ions occupy both sites, the metal ions have been observed to interact magnetically by spin exchange, suggesting that a common ligand, such as a phosphoryl group, bridges the metal ions. In this x-ray study, in spite of the absence of substrates, two divalent metal ions are found in the active site, suggesting that the binding mode of the two P(i) ions at the active site is somehow similar to that of the triphosphate group of ATP. In fact, the coordination scheme between the P(i) ions and the divalent metal ions found in this study is consistent with the EPR observation described above.

Two divalent ions are found at the active site in structures of the 3`,5`-exonuclease domain of DNA polymerase I(51) . In the absence of substrate or product, the exonuclease domain of DNA polymerase I has one bound divalent metal ion (site A), whereas complexes with deoxynucleoside monophosphates show a second divalent metal ion (site B) separated by 4 Å from that in site A. Thus, MAT and DNA polymerase I may belong to an emerging group of structurally determined members of a family of nucleotide-utilizing enzymes that bind multiple divalent metal ions.

The active site K ion is surrounded by three oxygen atoms within coordination distance (O1 and O2 of Glu and O of Ser), but there is no interaction with the P(i) ions. Thus, the monovalent ion appears to aid in construction of the framework of the active site, a situation analogous to that recently found for K ion pyruvate kinase(52) . Although there is no significant electron density peak which might indicate water molecules around the K ion, several water molecules should be coordinated to the K ion since there are two large open spaces around the K ion and the coordination number of K is often as large as 10 (53) . The binding site of the K ion is the same as that of one of the UO(2) binding sites in the heavy atom derivative, consistent with UO(2) being an inhibitor of the enzyme(54) . On the basis of this crystal structure, a site-directed mutagenesis change of Glu to Gln has been carried out by McQueney and Markham(54) . The mutation abolished the monovalent cation activation and produced an enzyme which has an activity virtually identical with that of K-free wild type MAT in both the overall AdoMet synthesis reaction and in the hydrolysis of tripolyphosphate, indicating that the monovalent and divalent metal ions in the active site were assigned correctly. It should be noted that all amino acid residues involved in either hydrogen bonds or coordination bonds with either metal ions or P(i) ions are conserved in the 12 reported sequences of MAT.

In summary, this crystallographic study on MAT from E. coli has revealed the active sites of the tetrameric enzyme which are located between the subunits forming a spherical tight dimer. Two divalent metal ions (Mg) and one monovalent metal ion (K) have been found along with two P(i) ions (one of the products of the reaction catalyzed by MAT) in the active site. The Mg binding sites have been confirmed from the cobalt atom position found in the MAT-Co derivative. The two Mg ions bridge two P(i) ions, and Mg(1) and Mg(2) ions are surrounded by Glu^8*, Asp, and Asp residues, and Asp*, Glu, and Cys* residues, respectively. The binding site (Glu) of the K ion is the same as that of one of the UO(2) ion binding sites in the heavy atom derivative. Consequently, UO(2) ion is an inhibitor of the enzyme. The K ion bound on Glu has been confirmed by a site-directed mutagenesis (E42Q). The mutation abolished the monovalent cation activation and produced an enzyme which has an activity virtually identical with that of K-free wild type MAT. The positively charged amino acid residues, His^14, Lys, Lys, and Lys interact strongly with the P(i) ions, suggesting that some of those amino acid residues are involved in the unusual two-step catalytic reaction. These amino acid residues as well as the amino acid residues interacting with the monovalent and divalent metal ions in the active site are all conserved in the 12 reported sequences of MATs from various species, indicating that the MATs assume quite similar three-dimensional structures including the active site geometry. Therefore, the central features of the mechanism of the catalytic reactions are probably identical in the enzymes from a wide range of organisms.


FOOTNOTES

*
The work carried out at the University of Kansas was supported by National Institutes of Health Grant GM37233 and in part by the Kansas Health Foundation and the Marion Merrell Dow Foundation. The work carried out at The Fox Chase Cancer center has been supported by National Institutes of Health Grants GM31186, CA06927, and RR05539 and by an appropriation from the Commonwealth of Pennsylvania. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates (code 1XRA, 1XRB, and 1XRC) have been deposited in the Protein Data Bank, Brookhaven National Laboratory, Upton, NY.

§
To whom correspondence should be addressed: Dept. of Chemistry, Malott Hall, University of Kansas, Lawrence, KS 66045-0046. Tel.: 913-864-4727; Fax: 913-864-5396.

(^1)
The abbreviations used are: AdoMet, S-adenosylmethionine; SeMet, L-selenomethionine; MAT, ATP:L-methionine S-adenosyltransferase; SeMAT, the MAT enzyme in which methionine residues were all replaced with selenomethionine residues; MAT-Co, the enzyme containing the Co ions in the active site; MAT-U, the isomorphous UO(2) derivative of MAT; SIR, single isomorphous replacement; MIR, multiple isomorphous replacement.


ACKNOWLEDGEMENTS

The excellent facilities and helpful cooperation provided by the National Institutes of Health Research Resources of the University of Virginia and the University of California at San Diego are gratefully acknowledged. We would like to thank John C. Taylor for construction and growth of the selenomethionine incorporating strain. We wish to express our thanks to Professor R. L. Schowen for a critical reading of this manuscript and very valuable comments.


REFERENCES

  1. Cantoni, G. L. (1953) J. Biol. Chem. 204, 403-416 [Free Full Text]
  2. Diliberto, E. J. (1982) in Cellular Relation of Secretion and Release (Conn, P. M., ed) pp. 147-192, Academic Press, New York
  3. Koshland, D. E., Jr. (1988) Biochemistry 27, 5829-5834 [Medline] [Order article via Infotrieve]
  4. Bouchard, P., Penningroth, S. M., Cheung, A., Gagnon, C. & Bardin, C. W. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 1033-1036 [Abstract]
  5. Billingsley, M. L. & Roth, R. H. J. (1982) J. Pharmacol. Exp. Ther. 223, 681-688 [Medline] [Order article via Infotrieve]
  6. Thomas, C. S., Bottiglieri, T., Edeh, J., Carney, M. W. P., Reynolds, E. H. & Toone, B. K. (1987) Int. Clin. Psychopharmacol. 2, 97-102 [Medline] [Order article via Infotrieve]
  7. Chawla, R. K., Bonkovsky, H. L. & Galambos, J. T. (1990) Drugs 40, 98-110 [Medline] [Order article via Infotrieve]
  8. Pascale, R. M., Marras, V., Simile, M. M., Daino, L., Pinna, G., Bennati, S., Carta, M., Seddaiu, M. A., Massarelli, G. & Feo, F. (1992) Cancer Res. 52, 4979-4986 [Abstract]
  9. Tabor, C. W. & Tabor, H. (1984) Adv. Enzymol. Relat. Areas Mol. Biol. 56, 251-282 [Medline] [Order article via Infotrieve]
  10. Jänne, J., Alhonen, L. & Leinonen, P. (1991) Ann. Med. 23, 241-259 [Medline] [Order article via Infotrieve]
  11. Pegg, A. E. (1988) Cancer Res. 48, 759-774 [Abstract]
  12. Regland, B. & Gottfries, C. G. (1992) Med. Hypotheses 38, 11-19 [Medline] [Order article via Infotrieve]
  13. Mudd, S. H. & Cantoni, G. L. (1958) J. Biol. Chem. 231, 481-492 [Free Full Text]
  14. Markham, G. D., DeParasis, J. & Gatmaitan, J (1984) J. Biol. Chem. 259, 14505-14507 [Abstract/Free Full Text]
  15. Satishchandran, C., Taylor, J. C. & Markham, G. D. (1993) Mol. Microbiol. 9, 835-846 [Medline] [Order article via Infotrieve]
  16. Thomas, D. & Surdin-Kerjan, Y. (1987) J. Biol. Chem. 262, 16704-16709 [Abstract/Free Full Text]
  17. Thomas, D., Rothstein, R., Rosenberg, N. & Surdin-Kerjan, Y. (1988) Mol. Cell. Biol. 8, 5132-5139 [Medline] [Order article via Infotrieve]
  18. Peleman, J., Saito, K., Cottyn, B., Engler, G., Seurinck, J., Van Montagu, M. & Inze, D. (1989) Gene (Amst.) 84, 359-369 [CrossRef][Medline] [Order article via Infotrieve]
  19. Peleman, J., Boerjan, W., Engler, G., Seurinck, J., Botterman, J., Alliotte, T., Van Montagu, M. & Inze, D. (1989) Plant Cell 1, 81-93 [Abstract/Free Full Text]
  20. Horikawa, S., Ishikawa, M., Ozasa, H. & Tsukada, K. (1989) Eur. J. Biochem. 184, 497-501 [Abstract]
  21. Horikawa, S., Sasuga, J., Shimizu, K., Ozasa, H. & Tsukada, K. (1990) J. Biol. Chem. 265, 13683-13686 [Abstract/Free Full Text]
  22. Horikawa, S. & Tsukada, K. (1991) Biochem. Int. 25, 81-90 [Medline] [Order article via Infotrieve]
  23. Horikawa, S. & Tsukada, K. (1992) FEBS Lett. 312, 37-41 [CrossRef][Medline] [Order article via Infotrieve]
  24. Larsen, P. B. & Woodson, W. R. (1991) Plant Physiol. 96, 997-999
  25. Gilliland, G. L., Markham, G. D. & Davies, D. R. (1983) J. Biol. Chem. 258, 6963-6964 [Abstract/Free Full Text]
  26. Markham, G. D., Hafner, E. W., Tabor, C. W. & Tabor, H. (1980) J. Biol. Chem. 255, 9082-9092 [Abstract/Free Full Text]
  27. Markham, G. D. (1981) J. Biol. Chem. 256, 1903-1909 [Abstract/Free Full Text]
  28. Hendrickson, W. A., Horton, J. R. & LeMaster, D. M. (1990) EMBO J. 9, 1665-1672 [Abstract]
  29. Xuong, Ng. H., Nielsen, C., Hamlin, R. & Anderson, D. (1985) J. Appl. Crystallogr. 18, 342-350 [CrossRef]
  30. Tanaka, I., Yao, M., Suzuki, M., Hikichi, K., Matsumoto, T., Kozasa, M. & Katayama, C. (1990) J. Appl. Crystallogr. 23, 334-339 [CrossRef]
  31. Takusagawa, F. (1992) J. Appl. Crystallogr. 25, 26-30 [CrossRef]
  32. Wang, B.-C. (1985) Methods Enzymol. 115, 90-112 [Medline] [Order article via Infotrieve]
  33. Harrison, C. J., Bohm, A. A. & Nelson, H. C. M. (1994) Science 263, 224-227 [Medline] [Order article via Infotrieve]
  34. Newman, M., Strzelecka, T., Dorner, L. F., Schildkraut, I. & Aggarwal, A. K. (1994) Nature 368, 660-664 [CrossRef][Medline] [Order article via Infotrieve]
  35. Jones, T. A. (1985) Methods Enzymol. 115, 157-171 [Medline] [Order article via Infotrieve]
  36. Cambillau, C. & Horjales, E. (1987) J. Mol. Graph. 5, 174 [CrossRef]
  37. Br ü nger, A. T. (1993) X-PLOR 3.1: A System for X-ray Crystallography and NMR , Yale University Press, New Haven
  38. Brünger, A. T. (1992) Nature 355, 472-475 [CrossRef]
  39. Luthy, R., Bowie, J. U. & Eisenberg, D. (1992) Nature 356, 83-85 [CrossRef][Medline] [Order article via Infotrieve]
  40. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291 [CrossRef]
  41. Ramakrishman, C. & Ramachandran, G. N. (1965) Biophys. J. 5, 909-933 [Medline] [Order article via Infotrieve]
  42. Lolis, E., Albert, T., Davenport, R. C., Rose, D., Hampton, F. C. & Petsko, G. A. (1990) Biochemistry 29, 6609-6618 [Medline] [Order article via Infotrieve]
  43. Abad-Zapatero, C., Griffith, J. P., Sussman, J. L. & Rossmann, M. G. (1987) J. Mol. Biol. 198, 445-467 [Medline] [Order article via Infotrieve]
  44. Vidgren, J., Svensson, L. A. & Liljas, A. (1994) Nature 368, 354-358 [CrossRef][Medline] [Order article via Infotrieve]
  45. Cheng, X., Kumar, S., Posfai, J., Pflugrath, J. W. & Roberts, R. J. (1993) Cell 74, 299-307 [Medline] [Order article via Infotrieve]
  46. Labahn, J., Granzin, J., Schluckebier, G., Robinson, D. P., Jack, W. E., Schildkraut, I. & Saenger, W. (1994) Natl. Acad. Sci. U. S. A. 91, 10957-10961 [Abstract/Free Full Text]
  47. Schluckebier, G., O'Gara, M., Saenger, W. & Cheng, X. (1995) J. Mol. Biol. 247, 16-20 [CrossRef][Medline] [Order article via Infotrieve]
  48. Rafferty, J. M., Somers, W. S., Saint-Girons, I. & Phillips, S. E. V. (1989) Nature 341, 705-710 [CrossRef][Medline] [Order article via Infotrieve]
  49. Markham, G. D. & Satishchandran, C. (1988) J. Biol. Chem. 263, 8666-8670 [Abstract/Free Full Text]
  50. Reczkowski, R. S. & Markham, G. D. (1991) FASEB J. 5, A1150
  51. Beese, L. S. & Steitz, T. A. (1991) EMBO J. 10, 25-33 [Abstract]
  52. Larsen, T. M., Laughlin, L. T., Holden, H. M., Rayment, I. & Reed, G. H. (1994) Biochemistry 33, 6301-6309 [Medline] [Order article via Infotrieve]
  53. Glusker, J. P. (1991) Adv. Protein Chem. 42, 1-76 [Medline] [Order article via Infotrieve]
  54. McQueney, M. S. & Markham, G. D. (1995) J. Biol. Chem. 270, 18277-18284 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.